Blogs

In a landmark reversal, the U.S. Food & Drug Administration (FDA) has confirmed that β-Nicotinamide Mononucleotide (NMN) is lawful for use in dietary supplements in the United States. In letters issued September 29, 2025, the FDA concluded that NMN qualifies as a dietary supplement ingredient, overturning its earlier exclusion under the “drug preclusion” clause.  A pivota …